The global E. coli testing market size reached US$ 2.1 Billion in 2023. Looking forward, the publisher expects the market to reach US$ 3.9 Billion by 2032, exhibiting a growth rate (CAGR) of 7.12% during 2023-2032.
Escherichia coli (E. Coli) testing refers to the process of detecting and monitoring the presence of foodborne pathogens. E. Coli bacteria is usually found in contaminated food and water, cheese manufactured from raw milk, undercooked products, unpasteurized milk and raw fruits and vegetables. It can cause various diseases, such as food poisoning, pneumonia and urinary tract infections (UTIs).
Some of the clinical testing methods for the detection of E. Coli include enzyme immunoassays (EIA) and polymerase chain reaction (PCR) tests, along with environmental testing methods, such as enzyme-substrate, membrane filtration and multiple tube fermentation (MTF). These techniques aid in obtaining an accurate and quantitative measure of total coliform and bacteria present in the sample.
The increasing prevalence of water-borne diseases, such as diarrhea and hemolytic uremic syndrome (HUS), along with the growing need for clean potable water across the globe, is one of the key factors creating a positive outlook for the market. E. Coli tests can aid in monitoring the quality of surface and drinking water to prevent the spread of illnesses and diseases. Furthermore, the widespread adoption of the enzyme-substrate test as a presence or absence (P/A) test is also driving the market growth. These tests are easy to perform, do not require sophisticated laboratory equipment and use hydrolyzable fluorogenic substrates to detect the presence of various enzymes produced by the bacteria.
Additionally, various technological advancements, such as the development of innovative bacterial diagnostic instruments and water testing methods, are contributing to the market growth. Other factors, including increasing health consciousness among the masses, along with extensive research and development (R&D) activities in the field of microbiology, are expected to drive the market further.
Escherichia coli (E. Coli) testing refers to the process of detecting and monitoring the presence of foodborne pathogens. E. Coli bacteria is usually found in contaminated food and water, cheese manufactured from raw milk, undercooked products, unpasteurized milk and raw fruits and vegetables. It can cause various diseases, such as food poisoning, pneumonia and urinary tract infections (UTIs).
Some of the clinical testing methods for the detection of E. Coli include enzyme immunoassays (EIA) and polymerase chain reaction (PCR) tests, along with environmental testing methods, such as enzyme-substrate, membrane filtration and multiple tube fermentation (MTF). These techniques aid in obtaining an accurate and quantitative measure of total coliform and bacteria present in the sample.
The increasing prevalence of water-borne diseases, such as diarrhea and hemolytic uremic syndrome (HUS), along with the growing need for clean potable water across the globe, is one of the key factors creating a positive outlook for the market. E. Coli tests can aid in monitoring the quality of surface and drinking water to prevent the spread of illnesses and diseases. Furthermore, the widespread adoption of the enzyme-substrate test as a presence or absence (P/A) test is also driving the market growth. These tests are easy to perform, do not require sophisticated laboratory equipment and use hydrolyzable fluorogenic substrates to detect the presence of various enzymes produced by the bacteria.
Additionally, various technological advancements, such as the development of innovative bacterial diagnostic instruments and water testing methods, are contributing to the market growth. Other factors, including increasing health consciousness among the masses, along with extensive research and development (R&D) activities in the field of microbiology, are expected to drive the market further.
Key Market Segmentation:
The publisher provides an analysis of the key trends in each sub-segment of the global E. coli testing market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, test type and end user.Breakup by Product:
- Consumables
- Instruments
Breakup by Test Type:
- Environmental Test
- Membrane Filtration (MF)
- Multiple Tube Fermentation (MTF)
- Enzyme Substrate Methods
- Clinical Test
- Polymerase Chain Reaction (PCR) Tests
- Enzyme Immunoassays (EIA)
- Others
Breakup by End User:
- Hospitals and Clinics
- Diagnostic Laboratories
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Accugen Laboratories Inc., Alere Inc. (Abbott Laboratories), BD (Becton Dickinson and Company), bioMérieux (INSTITUT MERIEUX), Bio-RAD Laboratories Inc., Enzo Life Sciences Inc. (Enzo Biochem Inc.), Idexx Laboratories Inc., Johnson & Johnson, Meridian Bioscience Inc., Nanologix Inc., Pro-Lab Diagnostics, Qiagen N.V. and Thermo Fisher Scientific Inc.Key Questions Answered in This Report:
- How has the global E. coli testing market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global E. coli testing market?
- What are the key regional markets?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the test type?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global E. coli testing market and who are the key players?
- What is the degree of competition in the industry?
Table of Contents
1 Preface3 Executive Summary11 Value Chain Analysis13 Price Analysis
2 Scope and Methodology
4 Introduction
5 Global E. Coli Testing Market
6 Market Breakup by Product
7 Market Breakup by Test Type
8 Market Breakup by End User
9 Market Breakup by Region
10 SWOT Analysis
12 Porters Five Forces Analysis
14 Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
- Accugen Laboratories Inc.
- Alere Inc. (Abbott Laboratories)
- BD (Becton Dickinson
- Company)
- bioMérieux (INSTITUT MERIEUX)
- Bio-RAD Laboratories Inc.
- Enzo Life Sciences Inc. (Enzo Biochem Inc.)
- Idexx Laboratories Inc.
- Johnson & Johnson
- Meridian Bioscience Inc.
- Nanologix Inc.
- Pro-Lab Diagnostics
- Qiagen N.V.
- Thermo Fisher Scientific Inc.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 149 |
| Published | August 2024 |
| Forecast Period | 2023 - 2032 |
| Estimated Market Value ( USD | $ 2.1 Billion |
| Forecasted Market Value ( USD | $ 3.9 Billion |
| Compound Annual Growth Rate | 7.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 14 |
